Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2010 Feb 5;3(3):319-22.

Sarcomatoid carcinoma of the prostate: a case report

Adamantia Zizi-Sermpetzoglou  1 , Vassiliki Savvaidou, Nikolaos Tepelenis, Nikolaos Galariotis, Michalis Olympitis, Konstantinos Stamatiou
Affiliations
Case Reports

Sarcomatoid carcinoma of the prostate: a case report

Adamantia Zizi-Sermpetzoglou et al. Int J Clin Exp Pathol. .

Abstract

Sarcomatoid carcinoma of the prostate is a rare variant of prostatic cancer, with less than 100 cases reported in the literature up to date. Tumors are most commonly composed of an admixture of both malignant glandular and spindle cell elements. The sarcomatoid component can vary from 5 to 99%. We report a case of a 76-year old Caucasian man who underwent transurethral resection of the prostate for the treatment of bladder outlet obstruction. Histopathologic examination revealed a tumor with malignant epithelial and sarcomatous elements. The malignant epithelial component consisted of poorly differentiated adenocarcinoma (Gleason score 5+4=9/10) and the sarcomatous component was mainly composed of undifferentiated spindle cells. On immunohistochemistrythe latter expressed a positive staining for vimentin. Several cells were positively stained for cytockeratin AE3 and myoD1 while all were negative for actin, desmin and myogenin. The diagnosis of sarcomatoid carcinoma was finally made. Although sarcomatoid carcinoma of the prostate is a highly aggressive neoplasm and patients have a poor prognosis, our patient is still alive one year after diagnosis.

Keywords: Prostate cancer; carcinosarcoma; cytokeratin AE1/3; immunohistochemistry; sarcomatoid carcinoma; vimentin.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Poorly differentiated adenocarcinoma of the prostate (H&E×20).
Figure 2
Figure 2
Spindle shaped pleomorphic neoplasm (H&E×20).
Figure 3
Figure 3
Prostate carcinoma expressing PSAP (PSAP×20).
Figure 4
Figure 4
Spindle cells expressing vimentin (VIM×40).
Figure 5
Figure 5
A few spindle giant cells positively stained for CKAE3 (CKAE3×40).
Figure 6
Figure 6
Several spindle giant cells positively stained for MyoD1 (MyoD1×40).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Mostofi FK, Price EB. Atlas of Tumor Pathology: Tumors of Male Genital System, series 2, part 8. Washington, DC: Armed Forces Institute of Pathology; 1973. Malignant tumors of the prostate; pp. 257–258.
    1. Grignon DJ. Unusual subtypes of prostate cancer. Mod Pathol. 2004;17(3):316–27. - PubMed
    1. World Health Organization Classification of Tumors, editor. Lyon: IARC Press; 2004. Pathology and Genetics of Tumors of the Urinary System and Male Genital Organs.
    1. Berney DM, Ravi R, Baithun SI. Prostatic carcino-sarcoma with squamous cell differentiation: a consequence of hormonal therapy. Report of two cases and review of the literature. J Urol Pathol. 1979;11:123–32.
    1. Hansel DE, Epstein JI. Sarcomatoid carcinoma of the prostate: a study of 42 cases. Am J Surg Pathol. 2006;30:1316–21. - PubMed

Publication types